ClinConnect ClinConnect Logo
Search / Trial NCT06983353

Guided Growth Technique Use In Treatment Of Hip Sublaxation In CP Childern

Launched by MOHAMED ADEL FATHY ABDEL ALEEM · May 13, 2025

Trial Information

Current as of July 27, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment method called the Guided Growth Technique to help children with Cerebral Palsy (CP) who have a condition known as hip subluxation. The goal of the study is to see how this technique can improve the angle of the thigh bone in children aged 3 to 12 years, specifically those who have a certain degree of hip displacement but are not severely affected.

To be eligible for this trial, children must be between 3 and 12 years old, diagnosed with CP, and have a specific angle in their thigh bone that is greater than 150 degrees. They should also have early signs of hip subluxation, meaning their hip is not fully in place but is still at a manageable level. Unfortunately, children with more severe hip issues or other medical conditions that could complicate surgery won't be able to participate. If chosen for the trial, participants will undergo a procedure involving screws that help guide the growth of the hip joint. This study is not yet recruiting, so it's a great opportunity for families to learn about potential new treatments for hip issues in CP.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • children aged 3-12 yrs diagnosed with CP ( GMFCS level l_lV )
  • Neck-Shaft angle \>150
  • early hip sub laxation ( migration percentage \< 50% )
  • Exclusion Criteria:
  • Sever hip sub laxation ( migration percentage\> 50 % )
  • Children below 3 yrs and above 12
  • Pathological bone
  • medical contraindications to surgery

About Mohamed Adel Fathy Abdel Aleem

Dr. Mohamed Adel Fathy Abdel Aleem is an esteemed clinical trial sponsor with extensive expertise in the development and management of innovative therapeutic solutions. With a strong background in medical research and a commitment to advancing healthcare, Dr. Abdel Aleem oversees a portfolio of clinical trials aimed at evaluating the safety and efficacy of novel treatments. His leadership is characterized by a focus on rigorous scientific methodologies and regulatory compliance, ensuring that all trials are conducted ethically and effectively. Through collaboration with multidisciplinary teams and adherence to best practices, he strives to contribute to the advancement of medical knowledge and improve patient outcomes.

Locations

Assiut, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported